Lista de obras -

101 Long-Term Survivors Who Had Metastatic Gastroesophageal Cancer and Received Local Consolidative Therapy.

artículo científico publicado en 2017

A Phase II Trial of Cytoreduction, Gastrectomy, and Hyperthermic Intraperitoneal Perfusion with Chemotherapy for Patients with Gastric Cancer and Carcinomatosis or Positive Cytology

scientific article published on 17 June 2020

Co-morbidities Rather than Age Impact Outcomes in Patients Receiving Preoperative Therapy for Gastroesophageal Adenocarcinoma.

artículo científico publicado en 2016

Esophageal Cancer Clinical Practice Guidelines

scientific article published on 01 April 2006

Factors associated with local-regional failure after definitive chemoradiation for locally advanced esophageal cancer.

artículo científico publicado en 2013

Gastric Cancer Clinical Practice Guidelines

scientific article published on 01 April 2006

Imaging-based biomarkers: Changes in the tumor interface of pancreatic ductal adenocarcinoma on computed tomography scans indicate response to cytotoxic therapy

artículo científico publicado en 2018

Local Control and Toxicity of a Simultaneous Integrated Boost for Dose Escalation in Locally Advanced Esophageal Cancer: Interim Results from a Prospective Phase I/II Trial.

artículo científico publicado en 2016

Metastatic Gastroesophageal Adenocarcinoma Patients Treated with Systemic Therapy Followed by Consolidative Local Therapy: A Nomogram Associated with Long-Term Survivors

artículo científico publicado en 2016

Nodal Downstaging in Gastric Cancer Patients: Promising Survival if ypN0 is Achieved

scientific article published on 10 May 2018

Phase I Trial of Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) with Cisplatin, Mitomycin, and Paclitaxel in Patients with Gastric Adenocarcinoma and Associated Carcinomatosis or Positive Cytology

scientific article published on 23 January 2020

Preoperative Chemoradiation versus Chemotherapy in Gastroesophageal Junction Adenocarcinoma

artículo científico publicado en 2020

Preoperative Therapy and Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: a 25-Year Single-Institution Experience

artículo científico publicado en 2016

Results of a Phase 1/2 Trial of Chemoradiotherapy With Simultaneous Integrated Boost of Radiotherapy Dose in Unresectable Locally Advanced Esophageal Cancer

scientific article published on 17 September 2019

Severe lymphopenia during neoadjuvant chemoradiation for esophageal cancer: A propensity matched analysis of the relative risk of proton versus photon-based radiation therapy

artículo científico publicado en 2017

The ypT category does not impact overall survival in node negative gastric cancer

artículo científico publicado en 2018

Treatment Patterns for Gastroesophageal Junction Adenocarcinoma in the United States

artículo científico publicado en 2020

Utility of endoscopic ultrasound-guided fine-needle aspiration of regional lymph nodes that are proximal to and far from the primary distal esophageal carcinoma.

artículo científico publicado en 2017

Yield of peritoneal cytology in staging patients with gastric and gastroesophageal cancer

scientific article published on 14 October 2019

Lista de obras de

101 Long-Term Survivors Who Had Metastatic Gastroesophageal Cancer and Received Local Consolidative Therapy.

A Phase II Trial of Cytoreduction, Gastrectomy, and Hyperthermic Intraperitoneal Perfusion with Chemotherapy for Patients with Gastric Cancer and Carcinomatosis or Positive Cytology

Co-morbidities Rather than Age Impact Outcomes in Patients Receiving Preoperative Therapy for Gastroesophageal Adenocarcinoma.

Esophageal Cancer Clinical Practice Guidelines

Factors associated with local-regional failure after definitive chemoradiation for locally advanced esophageal cancer.

Gastric Cancer Clinical Practice Guidelines

Imaging-based biomarkers: Changes in the tumor interface of pancreatic ductal adenocarcinoma on computed tomography scans indicate response to cytotoxic therapy

Local Control and Toxicity of a Simultaneous Integrated Boost for Dose Escalation in Locally Advanced Esophageal Cancer: Interim Results from a Prospective Phase I/II Trial.

Metastatic Gastroesophageal Adenocarcinoma Patients Treated with Systemic Therapy Followed by Consolidative Local Therapy: A Nomogram Associated with Long-Term Survivors

Nodal Downstaging in Gastric Cancer Patients: Promising Survival if ypN0 is Achieved

Phase I Trial of Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) with Cisplatin, Mitomycin, and Paclitaxel in Patients with Gastric Adenocarcinoma and Associated Carcinomatosis or Positive Cytology

Preoperative Chemoradiation versus Chemotherapy in Gastroesophageal Junction Adenocarcinoma

Preoperative Therapy and Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: a 25-Year Single-Institution Experience

Results of a Phase 1/2 Trial of Chemoradiotherapy With Simultaneous Integrated Boost of Radiotherapy Dose in Unresectable Locally Advanced Esophageal Cancer

Severe lymphopenia during neoadjuvant chemoradiation for esophageal cancer: A propensity matched analysis of the relative risk of proton versus photon-based radiation therapy

The ypT category does not impact overall survival in node negative gastric cancer

Treatment Patterns for Gastroesophageal Junction Adenocarcinoma in the United States

Utility of endoscopic ultrasound-guided fine-needle aspiration of regional lymph nodes that are proximal to and far from the primary distal esophageal carcinoma.

Yield of peritoneal cytology in staging patients with gastric and gastroesophageal cancer